The Protective Effect of SDS-SeNPs on Protein and the Dynamic Change of Neutralizing Antibody of COVID-19 (IMAGE)
Caption
SDS‑SeNPs stabilize protein structure and activity for use in lateral flow immunoassay. A long-term follow‑up of 1,328 samples shows that neutralizing antibody levels fluctuate with Omicron subvariant circulation, and patients with neurological or hematological diseases exhibit accelerated antibody decline.
Credit
©Science Bulletin
Usage Restrictions
use with credit.
License
Original content